-
Sunlight-heated refugia protect frogs from chytridiomycosis: a mathematical modelling study
Authors:
Claire M. Miller,
Michael J. Lydeamore,
Lee Berger,
Lee F. Skerratt,
Jennifer A. Flegg,
Anthony W. Waddle,
Patricia Therese Campbell
Abstract:
The fungal disease Chytridiomycosis poses a threat to frog populations worldwide. It has driven over 90 amphibian species to extinction and severely affected hundreds more. Difficulties in disease management have shown a need for novel conservation approaches.
We present a novel mathematical model for chytridiomycosis transmission in frogs that includes the natural history of infection, to test…
▽ More
The fungal disease Chytridiomycosis poses a threat to frog populations worldwide. It has driven over 90 amphibian species to extinction and severely affected hundreds more. Difficulties in disease management have shown a need for novel conservation approaches.
We present a novel mathematical model for chytridiomycosis transmission in frogs that includes the natural history of infection, to test the hypothesis that sunlight-heated refugia reduce transmission. The model is fit using approximate Bayesian computation to experimental data where a cohort of frogs, a fixed subset of which had cleared a prior infection, were provided access to either sunlight-heated or shaded refugia. Using our model, we can estimate the extent to which prior chytridiomycosis infection protects against subsequent infection, and quantify the effect of sunlight-heating of refugia.
Results estimate a 40% reduction in chytridiomycosis transmission when frogs have access to sunlight-heated refugia, compared to shaded refugia. This strongly supports the hypothesis that the sunlight-heated refugia reduce disease transmission. Frogs that were infected and recovered were estimated to have a reduction in susceptibility of approximately 97% compared to frogs with no prior infection.
This research provides quantitative evidence supporting sunlight-heated refugia as an effective disease management tool for chytridiomycosis in frog populations. By estimating both the impact of refugia and the protective effects of prior infection, the model provides an evidence base for implementing sunlight-heated refugia as part of amphibian conservation strategies. This work represents an important first step in using mathematical modelling to inform policy on the design and implementation of habitat-based interventions to support amphibian population recovery and long-term sustainability.
△ Less
Submitted 4 May, 2025; v1 submitted 9 March, 2025;
originally announced March 2025.
-
Global and local epidemiology of Group A Streptococcus indicates that naturally-acquired immunity is enduring and strain-specific
Authors:
Rebecca H. Chisholm,
Jake A. Lacey,
Jan Kokko,
Patricia T. Campbell,
Malcolm I. McDonald,
Jukka Corander,
Mark R. Davies,
Steven Y. C. Tong,
Jodie McVernon,
Nicholas Geard
Abstract:
The bacterium Group A Streptococcus (Streptococcus pyogenes, GAS) is a human-specific pathogen and a major cause of global morbidity and mortality. Despite decades of research our knowledge of GAS infection and immunity is incomplete, hampering vaccine design and other efforts to reduce disease prevalence. Epidemiological studies indicate positive associations between the prevalence of GAS-related…
▽ More
The bacterium Group A Streptococcus (Streptococcus pyogenes, GAS) is a human-specific pathogen and a major cause of global morbidity and mortality. Despite decades of research our knowledge of GAS infection and immunity is incomplete, hampering vaccine design and other efforts to reduce disease prevalence. Epidemiological studies indicate positive associations between the prevalence of GAS-related disease, the diversity of circulating strains and the degree of poverty in host populations. However, the infection and immune mechanisms underlying these associations are not clear. In this work, we use an agent-based model to demonstrate that observed diversity and prevalence are best accounted for by the hypothesis that GAS infection confers enduring strain-specific immunity, with reduced or absent cross-protection against infection by other strains. Our results suggest that the success of GAS vaccines will depend on their ability to elicit long-lasting cross-protective immunity over multiple strain types.
△ Less
Submitted 11 November, 2021;
originally announced November 2021.
-
Infection-acquired versus vaccine-acquired immunity in an SIRWS model
Authors:
Tiffany Leung,
Barry D Hughes,
Federico Frascoli,
Patricia T Campbell,
James M McCaw
Abstract:
Despite high vaccine coverage, pertussis has re-emerged as a public health concern in many countries. One hypothesis posed for re-emergence is the waning of immunity. In some disease systems, the process of waning immunity can be non-linear, involving a complex relationship between the duration of immunity and subsequent boosting of immunity through asymptomatic re-exposure.
We present and analy…
▽ More
Despite high vaccine coverage, pertussis has re-emerged as a public health concern in many countries. One hypothesis posed for re-emergence is the waning of immunity. In some disease systems, the process of waning immunity can be non-linear, involving a complex relationship between the duration of immunity and subsequent boosting of immunity through asymptomatic re-exposure.
We present and analyse a model of infectious disease transmission to examine the interplay between infection and immunity. By allowing the duration of infection-acquired immunity to differ from that of vaccine-acquired immunity, we explore the impact of the difference in durations on long-term disease patterns and prevalence of infection.
Our model demonstrates that vaccination may induce cyclic behaviour, and its ability to reduce the infection prevalence increases with both the duration of infection-acquired immunity and duration of vaccine-acquired immunity. We find that increasing vaccine coverage, while capable of leading to an increase in overall transmission, always results in a reduction in prevalence of primary infections, with epidemic cycles characterised by a longer interepidemic period and taller peaks.
Our results show that the epidemiological patterns of an infectious disease may change considerably when the duration of vaccine-acquired immunity differs from that of infection-acquired immunity. Our study highlights that for any particular disease and associated vaccine, a detailed understanding of the duration of protection and how that duration is influenced by infection prevalence is important as we seek to optimise vaccination strategies.
△ Less
Submitted 9 August, 2017;
originally announced August 2017.
-
A biological model of scabies infection dynamics and treatment explains why mass drug administration does not lead to elimination
Authors:
M. Lydeamore,
P. T. Campbell,
D. G. Regan,
S. Y. C. Tong,
R. Andrews,
A. C. Steer,
L. Romani,
J. M. Kaldor,
J. McVernon,
J. M. McCaw
Abstract:
Despite a low global prevalence, infections with Sarcoptes scabiei, or scabies, are still common in remote communities such as in northern Australia and the Solomon Islands. Mass drug administration (MDA) has been utilised in these communities, and although prevalence drops substantially initially, these reductions have not been sustained. We develop a compartmental model of scabies infection dyna…
▽ More
Despite a low global prevalence, infections with Sarcoptes scabiei, or scabies, are still common in remote communities such as in northern Australia and the Solomon Islands. Mass drug administration (MDA) has been utilised in these communities, and although prevalence drops substantially initially, these reductions have not been sustained. We develop a compartmental model of scabies infection dynamics and incorporate both ovicidal and non-ovicidal treatment regimes. By including the dynamics of mass drug administration, we are able to reproduce the phenomena of an initial reduction in prevalence, followed by the recrudescence of infection levels in the population. We show that even under a `perfect' two-round MDA, eradication of scabies under a non-ovicidal treatment scheme is almost impossible. We then go on to consider how the probability of elimination varies with the number of treatment rounds delivered in an MDA. We find that even with infeasibly large numbers of treatment rounds, elimination remains challenging.
△ Less
Submitted 11 December, 2016;
originally announced December 2016.
